Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-25 @ 9:16 PM
NCT ID:
NCT06016556
Pre Assignment Details:
Data was extracted from medical records of the participants and data was evaluated per objectives of this study in approximately 6 months of this study (study start date: 17-Oct-2023 to study completion date: 09-Apr-2024).
Recruitment Details:
Eligible participants who were prescribed nirmatrelvir, ritonavir (PAXLOVIDTM) in the Kingdom of Saudi Arabia (KSA) any day between 1-Apr-2022 to 30-Jun-2023 (15-month look back period) for corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARSCoV-2)- their data was included in this retrospective observational study.
Study:
NCT06016556
Study Brief:
Results Section:
NCT06016556